130 related articles for article (PubMed ID: 22522845)
1. Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.
Kakar S; Deng G; Smyrk TC; Cun L; Sahai V; Kim YS
Mod Pathol; 2012 Jul; 25(7):1040-7. PubMed ID: 22522845
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
[TBL] [Abstract][Full Text] [Related]
3. Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
Stefanius K; Ylitalo L; Tuomisto A; Kuivila R; Kantola T; Sirniö P; Karttunen TJ; Mäkinen MJ
Histopathology; 2011 Apr; 58(5):679-92. PubMed ID: 21457162
[TBL] [Abstract][Full Text] [Related]
4. Association between molecular subtypes of colorectal cancer and patient survival.
Phipps AI; Limburg PJ; Baron JA; Burnett-Hartman AN; Weisenberger DJ; Laird PW; Sinicrope FA; Rosty C; Buchanan DD; Potter JD; Newcomb PA
Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443
[TBL] [Abstract][Full Text] [Related]
5. BRAF(V600E) efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cells.
Oikonomou E; Makrodouli E; Evagelidou M; Joyce T; Probert L; Pintzas A
Neoplasia; 2009 Nov; 11(11):1116-31. PubMed ID: 19881948
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma.
Takashima Y; Kawamura H; Okadome K; Ugai S; Haruki K; Arima K; Mima K; Akimoto N; Nowak JA; Giannakis M; Garrett WS; Sears CL; Song M; Ugai T; Ogino S
Clin Microbiol Infect; 2024 May; 30(5):630-636. PubMed ID: 38266708
[TBL] [Abstract][Full Text] [Related]
7. Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas.
Raghav KP; Shetty AV; Kazmi SM; Zhang N; Morris J; Taggart M; Fournier K; Royal R; Mansfield P; Eng C; Wolff RA; Overman MJ
Oncologist; 2013; 18(12):1270-7. PubMed ID: 24149137
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtyping of colorectal cancer: time to explore both intertumoral and intratumoral heterogeneity to evaluate patient outcome.
Fearon ER; Carethers JM
Gastroenterology; 2015 Jan; 148(1):10-3. PubMed ID: 25451650
[No Abstract] [Full Text] [Related]
9. Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases.
Ugai T; Haruki K; Harrison TA; Cao Y; Qu C; Chan AT; Campbell PT; Akimoto N; Berndt S; Brenner H; Buchanan DD; Chang-Claude J; Fujiyoshi K; Gallinger SJ; Gunter MJ; Hidaka A; Hoffmeister M; Hsu L; Jenkins MA; Milne RL; Moreno V; Newcomb PA; Nishihara R; Pai RK; Sakoda LC; Slattery ML; Sun W; Amitay EL; Alwers E; Thibodeau SN; Toland AE; Van Guelpen B; Woods MO; Zaidi SH; Potter JD; Giannakis M; Song M; Nowak JA; Phipps AI; Peters U; Ogino S
Am J Gastroenterol; 2023 Apr; 118(4):712-726. PubMed ID: 36707929
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma.
Darwanto A; Kitazawa R; Maeda S; Kitazawa S
Cancer Sci; 2003 May; 94(5):442-7. PubMed ID: 12824891
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases.
Harlid S; Van Guelpen B; Qu C; Gylling B; Aglago EK; Amitay EL; Brenner H; Buchanan DD; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Drew DA; Figueiredo JC; French AJ; Gallinger S; Giannakis M; Giles GG; Gunter MJ; Hoffmeister M; Hsu L; Jenkins MA; Lin Y; Moreno V; Murphy N; Newcomb PA; Newton CC; Nowak JA; Obón-Santacana M; Ogino S; Potter JD; Song M; Steinfelder RS; Sun W; Thibodeau SN; Toland AE; Ugai T; Um CY; Woods MO; Phipps AI; Harrison T; Peters U
Int J Cancer; 2022 Aug; 151(3):348-360. PubMed ID: 35383926
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome methylation analysis of benign and malignant colorectal tumours.
Beggs AD; Jones A; El-Bahrawy M; Abulafi M; Hodgson SV; Tomlinson IP
J Pathol; 2013 Apr; 229(5):697-704. PubMed ID: 23096130
[TBL] [Abstract][Full Text] [Related]
13. RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification.
Lee SM; Oh H
Sci Rep; 2024 May; 14(1):11432. PubMed ID: 38763942
[TBL] [Abstract][Full Text] [Related]
14. Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies.
Hidaka A; Harrison TA; Cao Y; Sakoda LC; Barfield R; Giannakis M; Song M; Phipps AI; Figueiredo JC; Zaidi SH; Toland AE; Amitay EL; Berndt SI; Borozan I; Chan AT; Gallinger S; Gunter MJ; Guinter MA; Harlid S; Hampel H; Jenkins MA; Lin Y; Moreno V; Newcomb PA; Nishihara R; Ogino S; Obón-Santacana M; Parfrey PS; Potter JD; Slattery ML; Steinfelder RS; Um CY; Wang X; Woods MO; Van Guelpen B; Thibodeau SN; Hoffmeister M; Sun W; Hsu L; Buchanan DD; Campbell PT; Peters U
Cancer Res; 2020 Oct; 80(20):4578-4590. PubMed ID: 32816852
[TBL] [Abstract][Full Text] [Related]
15. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.
Lannagan TRM; Lee YK; Wang T; Roper J; Bettington ML; Fennell L; Vrbanac L; Jonavicius L; Somashekar R; Gieniec K; Yang M; Ng JQ; Suzuki N; Ichinose M; Wright JA; Kobayashi H; Putoczki TL; Hayakawa Y; Leedham SJ; Abud HE; Yilmaz ÖH; Marker J; Klebe S; Wirapati P; Mukherjee S; Tejpar S; Leggett BA; Whitehall VLJ; Worthley DL; Woods SL
Gut; 2019 Apr; 68(4):684-692. PubMed ID: 29666172
[TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal Adenocarcinoma.
Takeda K; Koi M; Okita Y; Sajibu S; Keku TO; Carethers JM
Cancer Res Commun; 2023 Sep; 3(9):1940-1951. PubMed ID: 37772997
[TBL] [Abstract][Full Text] [Related]
17. Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer.
Mouradov D; Greenfield P; Li S; In EJ; Storey C; Sakthianandeswaren A; Georgeson P; Buchanan DD; Ward RL; Hawkins NJ; Skinner I; Jones IT; Gibbs P; Ma C; Liew YJ; Fung KYC; Sieber OM
Gastroenterology; 2023 Jul; 165(1):104-120. PubMed ID: 36933623
[TBL] [Abstract][Full Text] [Related]
18. Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.
Atreya CE; Greene C; McWhirter RM; Ikram NS; Allen IE; Van Loon K; Venook AP; Yeh BM; Behr SC
J Natl Compr Canc Netw; 2016 Dec; 14(12):1536-1543. PubMed ID: 27956538
[TBL] [Abstract][Full Text] [Related]
19. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in Colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and molecular subtypes of colorectal cancer.
Murphy N; Newton CC; Song M; Papadimitriou N; Hoffmeister M; Phipps AI; Harrison TA; Newcomb PA; Aglago EK; Berndt SI; Brenner H; Buchanan DD; Cao Y; Chan AT; Chen X; Cheng I; Chang-Claude J; Dimou N; Drew D; Farris AB; French AJ; Gallinger S; Georgeson P; Giannakis M; Giles GG; Gruber SB; Harlid S; Hsu L; Huang WY; Jenkins MA; Laskar RS; Le Marchand L; Limburg P; Lin Y; Mandic M; Nowak JA; Obón-Santacana M; Ogino S; Qu C; Sakoda LC; Schoen RE; Southey MC; Stadler ZK; Steinfelder RS; Sun W; Thibodeau SN; Toland AE; Trinh QM; Tsilidis KK; Ugai T; Van Guelpen B; Wang X; Woods MO; Zaidi SH; Gunter MJ; Peters U; Campbell PT
J Natl Cancer Inst; 2023 Feb; 115(2):165-173. PubMed ID: 36445035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
